Killodox 50 Dry Syrup contains Cefpodoxime Proxetil 50mg/5ml, a third-generation cephalosporin antibiotic effective against a broad spectrum of bacterial infections. It is indicated for the treatment of respiratory tract infections such as bronchitis, pneumonia, and sinusitis, as well as urinary tract infections, skin and soft tissue infections, and otitis media caused by susceptible strains of bacteria. Cefpodoxime Proxetil acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death, thereby exerting a bactericidal effect. The dry syrup formulation is particularly suitable for pediatric patients who have difficulty swallowing tablets. Upon reconstitution, the syrup provides an accurate and palatable dosage form, enhancing compliance. Killodox 50 Dry Syrup should be administered as prescribed by a healthcare professional, with dosage adjusted according to the severity of infection and patient weight. It is important to complete the full course of therapy to prevent resistance development. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal pain. Hypersensitivity reactions, although rare, require immediate medical attention. Caution is advised in patients with a history of penicillin or cephalosporin allergy. This medication should be stored in a cool, dry place and used within the recommended period after reconstitution.